In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Moderated Posters Awards

Presenters from abstracts selected for a presentation in a Moderated Posters session during ESC Congress are in competition for the best Moderated Poster.

ESC365-2019-Visual-Grey.jpg

Review all abstracts and presentations on ESC 365, the Cardiology Knowledge Hub.

 

Moderated Posters Awards 2019

Congratulations to the winners of the Moderated Posters Awards Sessions 2019!

Winners by topics

  • Shoichiro Nohara
    Cardio-Oncology: insights from basic , clinical, data science - Cancer therapeutics-related heart failure from a cohort study using big data of electronic health record in japan
  • Marie Dam Lauridsen
    Challenges in contemporary management of coronary artery disease - Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study
  • Mark Andrew Peterzan
    Aortic valve replacement: diagnostic and treatment considerations - Determinants of left ventricular ATP availability measured in vivo and ex vivo in patients with severe aortic stenosis: correlation of creatine kinase activity with LVEF and ATP diffusion distance
  • Nikolaj Eldrup
    Prediction of outcomes in lower extremity artery disease - Clopidogrel compared to aspirin in symptomatic peripheral arterial disease, a nationwide cohort study
  • Juan F Iglesias
    PCI outcomes: focus on long term follow-up - Five-year outcomes in patients with diabetes mellitus treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents 
  • Manan Pareek
    Hypertension: epidemiology, targets and comorbidities - 2018 ESC/ESH guideline-recommended age categories and intensive blood pressure management in high-risk adults: insights from SPRINT
  • Susanne Jung
    Diabetes and the heart - Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes
  • Mona Ahmed
    Nuclear cardiology: from bench to bedside - Zirconium-89 labelled probe for molecular imaging of inflammation in experimental atherosclerosis 
  • Carlo Alberto Barcella
    Neuropsychiatric disease, substance abuse and the heart - Patients with psychiatric disorders have reduced chances of receiving optimal post-arrest cardiovascular management
  • Javier Lopez Pais
    Cardiovascular pharmacotherapy - Impact on the prognosis of treatment administrated in the daily clinical practice to patients with myocardial infarction with non-obstructive coronary arteries
  • Sameer Mehta
    Artificial intelligence M-health - Global telemedicine initiatives for combating ami
  • Tan Sock Hwee
    Functional genomics - Plasma proteomics identify plaque-related proteins that predict long-term recurrent coronary events in patients with acute coronary syndrome
  • Raffaele De Caterina
    Identifying and managing complications of atrial fibrillation - ETNA-AF Europe: First 1-year follow-up snapshot analysis of more than 7,500 AF patients treated with edoxaban in routine clinical practice 

Winners by sessions

Tuesday 03 September
  • Professor Keith Fox
    New approaches to risk prediction - Balancing risk and benefit in patients with atrial fibrillation: the GARFIELD-AF risk score
  • Doctor Javier Lopez Pais
    Cardiovascular pharmacotherapy - Impact on the prognosis of treatment administrated in the daily clinical practice to patients with myocardial infarction with non-obstructive coronary arteries
  • Doctor Tan Sock Hwee
    Functional genomics - Plasma proteomics identify plaque-related proteins that predict long-term recurrent coronary events in patients with acute coronary syndrome
  • Doctor Manan Pareek
    Hypertension: epidemiology, targets and comorbidities - 2018 ESC/ESH guideline-recommended age categories and intensive blood pressure management in high-risk adults: insights from SPRINT
  • Professor Dirk Westermann
    Mechanical circulatory support in acute coronary syndromes : are we turning in circles ?  - Multicenter analysis of left ventricular unloading on top of VA-ECMO for treatment of cardiogenic shock
  • Doctor Dong Oh Kang
    Stroke - The heart brain axis - Sleep-disordered breathing assessed by holter-monitoring is associated to worsened one-year clinical outcomes in ischemic stroke patients: a cardiopulmonary coupling analysis
  • Doctor Marcelo Bastos
    Advanced PCI techniques - Haemodynamical effects o fleft ventricular assistance during high-risk percutaneous coronary interventions with a pneumatic left ventricular assist device
  • Dr Satish Ramkumar
    The role of imaging for pacing candidates and arrhythmias - Impact of disease stage on performance of strain markers for prediction of atrial fibrillation
  • Dr Marianna Cicenia
    Cardiovascular risks of surgery and of TAVI - Impact of radiotherapy on myocardial function and paravalvular leaks after transcatheter aortic valve implantation (TAVI)
  • Dr Ekaterina Zhiduleva
    Basic mechanism of valvular heart disease -  Cellular mechanisms of aortic valve calcification in primary human valvular interstitial cell culture
  • Dr Belal Mohamed
    Translational research in heart failure - The Phosphodiesterase 4D interacting protein averts volume overload- but not pressure overload-induced pathological myocardial remodeling
  • Dr Peter Emanuel Ong
    Functional coronary disease in patients with acute coronary syndromes Safety assessment and results of coronary spasm provocation testing in patients with MINOCA compared to patients with stable angina and unobstructed coronary arteries
  • Dr Takahiro Hiraide
    Basic mechanisms of pulmonary disease - Poor outcomes in pulmonary arterial hypertension as a member of RNF213-associated vascular diseases
  • Dr Jayanthi Koneru
    Is his bundle pacing the new answer ? His bundle pacing in patients with abnormal versus intact atrioventricular conduction: from the IMAGE-HBP Study
  • Dr. Dao W Wang
    Channelopathies - from all to bedside - Pathogenic mechanism of DSG2-F531C mutation caused arrhythmogenic right ventricular cardiomyopathy
  • Ms. Marta Skowronska
    Novel imaging and risk stratification of acute pulmonary embolism - Modified CT-based Bova score may improve the classification of patients with acute pulmonary embolism at risk of adverse events
  • Ms. Marie Dam Lauridsen
    Challenges in contemporary management of coronary artery disease - Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study
  • Prof. Chim Choy Lang
    Glucose abnormalities and left ventricular dysfunction - Peripheral neuropathy and increased risk of heart failure: a population-based longitudinal cohort study
  • Ms. Anne-Marie Koop
    Determinants of heart failure: hypertrophy and fibrosis - The adult heart requires baseline expression of the transcription factor Hand2 to withstand right ventricular pressure overload
  • Dr. Miriam Pineiro-Portela
    Advances in stress echocardiography in different clinical scenarios - Long term follow up after comparison of two strategies in a chest pain unit: exercise echocardiography and multidetector computed tomography
  • Prof. Roland Schmieder
    Diabetes and the heart - Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes
Monday 02 September
  • Assistant Professor Hua Pan
    Innovations in CMR for coronary artery disease - Anti-thrombin nanoparticles limit ischemia-reperfusion injury and no-reflow in myocardial infarction
  • Mr Nicolai Mikkelsen
    Cardiopulmonary exercise and rehabilitation - Effect of cardiac rehabilitation predicts event-free survival
  • Miss Susana Bernal Uribe
    Vascular remodelling from capillaries to aorta - Protective effect of SOCS1-based therapy in experimental abdominal aortic aneurysm
  • Doctor Shoichiro Nohara
    Cardio-Oncology: insights from basic, clinical, data science - Cancer therapeutics-related heart failure from a cohort study using big data of electronic health record in japan
  • Doctor Olivier Barthelemy
    Revascularisation strategies in ACS - Predictive value of the residual SYNTAX score following primary PCI in multivessel patients with MI-related cardiogenic shock - a CULPRIT SHOCK sub-analysis
  • Assistant Professor Amy Sanyahumbi
    Global perspective on rheumatic heart disease - Evolution of subclinical rheumatic heart disease: a multi-centre retrospective cohort study
  • Professor Christoph Thomas Starck
    Challenges in lead extraction - Percutaneous aspiration procedure as an adjunct to transvenous lead extraction procedures in patients with large lead vegetations
  • Mr. Johan Skov Bundgaard
    Costs in different public health settings - The economic burden of heart failure in denmark from 1998 to 2016
  • Mr. Martin Lindgren
    New approaches in risk stratification - Resting heart rate in late adolescence and long term risk of cardiomyopathy - A nationwide study of one million Swedish men
  • Dr. Giorgia Beffagna
    Novel anti-arrhythmic therapies - Zebrafish models for arrhythmogenic cardiomyopathy type 8: a starting platform for exercise stress test and drug treatment
  • Dr. Filip Loncaric
    The heart in hypertension - Myocardial work distribution in hypertensive patients with basal septal hypertrophy - a non-invasive assessment with left ventricular pressure-strain relations 
  • Dr. Maria Asuncion Esteve Pastor
    Insights from acute coronary syndrome registries - One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry
  • Dr. Michela Giustozzi
    Updates in venous thromboembolism - Impact of sex and risk factors for venous thromboembolism on the clinical course of first acute venous thromboembolism. Insights from the PREFER in VTE
  • Dr. Anat Berkovitch
    TAVR outcomes: the future is here - Validation of the cardiac damage classification and additional effects of albumin levels in a large cohort of patients undergoing transcatheter aortic valve replacement
  • Dr. Carlo Alberto Barcella
    Neuropsychiatric disease, substance abuse and the heart - Patients with psychiatric disorders have reduced chances of receiving optimal post-arrest cardiovascular management
  • Dr. Henrik Ten Freyhaus
    Vascular inflammation - The six-transmembrane protein Stamp2 protects from hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via actions in mononuclear cells and CXCL12
  • Dr. Kieran Docherty
    Real world heart failures populations - Declining risk of heart failure hospitalisation following first acute myocardial infarction in Scotland between 1990-2015
  • Dr. Akira Suda
    New perspective on pathophysiology and mechanisms in coronary artery disease - Coexistence and prognostic impacts of epicardial and microvascular coronary dysfunctions in patients with chest pain and unobstructive coronary artery disease -Involvement of Rho-kinase activation
  • Dr. Eva Freisinger
    Hot topics in treatment of congenital heart disease - Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
  • Dr. John Giudicessi
    Update on sudden cardiac death - Prevalence and potential genetic determinants of young sudden unexplained death victims with suspected arrhythmogenic mitral valve prolapse
  • Dr. Laura Houard
    State of the art cardiovascular magnetic resonance - cMR-Pulmonary transit time and pulmonary blood volume have an additional prognostic value over cMR-right ventricular ejection fraction in predicting mortality in HF-rEF patients
Sunday 01 September
  • Prof. Vincent Probst
    News on the ICD front, the transveneous, the subcutaneous and the wearable - First clinical evaluation of subcutaneous implantable cardiac defibrillator in Brugada patients
  • Dr. Mark Andrew Peterzan
    Aortic valve replacement: diagnostic and treatment considerations - Determinants of left ventricular ATP availability measured in vivo and ex vivo in patients with severe aortic stenosis: correlation of creatine kinase activity with LVEF and ATP diffusion distance
  • Mr. Pedro Ivo De Marqui Moraes
    Assessment and management of patients with myocardial infraction and shock - IABP-SHOCK II risk score validation for cardiogenic shock after myocardial infarction in a cohort treated with pharmaco-invasive therapy
  • Dr. Harriette Van Spall
    Heart failure: aspects of aging and cognition - Intensity and cost of health care at the end of life among patients with heart failure
  • Dr. Dhite Bayu Nugroho 
    Cardiovascular ageing - Senescence associated secretory phenotype exacerbates overload pressure-cardiac hypertrophy
  • Mrs. Mette Soegaard
    The female heart from cradle to grave - Maternal and foetal outcomes of anticoagulation in pregnant women with preconception venous thromboembolism 
  • Dr. Abdul Rahman Ihdayhid
    Present & Future of cardiac Computed Tomography - Prognostic value and incremental benefit of ischaemic myocardial burden subtended by non-invasive CT-derived fractional flow reserve (FFRCT) significant stenoses
  • Dr. Juan F Iglesias
    PCI outcomes: focus on long term follow-up - Five-year outcomes in patients with diabetes mellitus treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents 
  • Associate Professor Nikolaj Eldrup
    Prediction of outcomes in lower extremity artery disease - Clopidogrel compared to aspirin in symptomatic peripheral arterial disease, a nationwide cohort study
  • Dr. Thomas Steen Gyldenstierne Sehested
    New applications of risk assessment in coronary artery disease - Risk of upper gastrointestinal bleeding following myocardial infarction: a novel prediction model for assessing appropriateness of proton pump inhibition therapy
  • Dr. Okello Samson
    Hypertension around the world - Hypertension prevalence, awareness, treatment and control and 10-year estimated CVD risk in East and West Africa: pooled analysis of data from 4 African countries
  • Mr. Mark Colin Gissler
    Vascular signalling - Tumor necrosis factor receptor-associated factor 5 (TRAF-5) deficiency exacerbates diet-induced adipose tissue inflammation and aggravates metabolic syndrome in mice
  • Dr. Dominick Joseph Angiolillo
    Evolving developments in anti-platelet therapy - Platelet inhibitory profiles of prasugrel versus ticagrelor in patients with CYP2C19 loss-of-function genotypes undergoing percutaneous coronary intervention: results of a randomized feasibility study
  • Dr. Sameer Mehta
    Artificial intelligence M-health - Global telemedicine initiatives for combating ami
  • Dr. Mona Ahmed
    Nuclear cardiology: from bench to bedside - Zirconium-89 labelled probe for molecular imaging of inflammation in experimental atherosclerosis
  • Prof. Gregory Schwartz
    How good/bad are we in treating lipids - Very low achieved low-density lipoprotein cholesterol level with alirocumab treatment after acute coronary syndrome: ODYSSEY OUTCOMES
  • Dr. Soeren Brandenburg
    Insight into atrial physiology and pathology - Impact of regulated junctophilin-2 clustering at axial tubule junctions on atrial excitation-contraction coupling and therapeutic implications
  • Dr. Aaron Koshy
    CRT: specific populations and novel imaging techniques of cardiac mechanics -  Revealing cardiac mechanics with CMR whilst CRT is active: the first step
  • Dr. Flavie Ader
    Clinical, imaging and genetic advances in hypertrophic cardiomyopathy -  FLNC pathogenic variants in patients with various cardiomyopathies:prevalence and genotype-phenotype correlations
  • Dr. Dong Oh Kang
    Assessment of residual risk after percutaneous coronary intervention - Prognostic impact of sarcopenia on major adverse cardiovascular outcomes in coronary artery disease patients undergoing successful percutaneous coronary intervention
  • Prof. Raffaele De Caterina
    Identifying and managing complications of atrial fibrillation - ETNA-AF Europe: First 1-year follow-up snapshot analysis of more than 7,500 AF patients treated with edoxaban in routine clinical practice

 

Saturday 31 August
  • Dr. Konstantinos Papadopoulos 
    News on advanced echocardiographic in valvular heart disease - Preserved global longitudinal strain predicts left ventricular reverse remodeling one year after edge-to-edge mitral valve repair in functional mitral regurgitation
  • Dr. Pierre-Laurent Massoure 
    Physiologic limits of athlete's heart - Cardiac damage induced by long term and intensive endurance exercise training in senior athletes: a cardiac magnetic resonance and exercise echocardiography analysisPreserved global longitudinal strain predicts left ventricular reverse remodeling one year after edge-to-edge mitral valve repair in functional mitral regurgitation
  • Ms. Lindsey Dugaucquier
    Insights into cardiac cell biology for repair and regeneration - The cardiac endothelial cell transcriptome in neonatal, adult, and remodeling heartsPreserved global longitudinal strain predicts left ventricular reverse remodeling one year after edge-to-edge mitral valve repair in functional mitral regurgitation
  • Dr. Maria AmaliaTamargo Delpon
    Novelties in pathophysiology of heart failure with preserved ejection fraction - Haemodynamic implications of mitral regurgitation in heart failure with preserved ejection fractionPreserved global longitudinal strain predicts left ventricular reverse remodeling one year after edge-to-edge mitral valve repair in functional mitral regurgitation
  • Dr. Talia Dalcoquio 
    Pharmaco intervention and mechanisms in acute coronary syndromes - Effect of exercise stress test on platelet function in patients with recent acute myocardial infarction
  • Dr. Juan Ramon Gimeno Blanes
    Dilated, infiltrative and inflammatory cardiomyopathies - Prospective FU in various subtypes of cardiomyopathies: insights from the EORP Cardiomyopathy Registry of the ESCPreserved global longitudinal strain predicts left ventricular reverse remodeling one year after edge-to-edge mitral valve repair in functional mitral regurgitation
  • Mr. Daniel Mol
    New insights in atrial fibrillation ablation: techniques and complications - More procedural complications in female patients undergoing pulmonary vein ablation in atrium fibrillation: results from 12,430 patients in the netherlands heart registryProspective FU in various subtypes of cardiomyopathies: insights from the EORP Cardiomyopathy Registry of the ESCPreserved global longitudinal strain predicts left ventricular reverse remodeling one year after edge-to-edge mitral valve repair in functional mitral regurgitation

 

Moderated Posters Awards 2018

Congratulations to the winners of the Moderated Posters Awards Sessions 2018!

Overall winners by topics

  • Dr. Leonardo Seoane
    Modifying outcomes in cardiovascular surgery - Prognostic value of the leukoglycaemic index in postoperative of coronary artery bypass grafting
  • Dr. Ify Mordi
    Diagnostic toolkit for a dilated aorta - The novel biomarker plasma desmosine, a marker of elastin breakdown, is an independent predictor of abdominal aortic aneurysm events independent of aneurysm size
  • Dr. Ryo Nishinarita
    Atrial fibrillation - General 2 - SGLT 2 inhibitor suppresses atrial fibrillation in the canine model of atrial fibrillation.
  • Dr. Albert Busch
    Role of non coding RNAs in cardiovascular diseases - Long non-coding RNA H19 induces abdominal aortic aneurysms
  • Dr. Jairo Borges
    The ageing heart: a target for interventions and aggressive pharmacotherapy - Normal blood pressure by ACC / AHA 2017 is associated with higher mortality in older adults with hypertension over 1 year. Results of the SARCOS study.
  • Dr. Morten Lamberts
    Oral anticoagulants : news from large trials and registries - Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study
  • Dr. Fernando Scudiero
    Specials in cardiology: obstructive sleep apnea and Takotsubo syndrome - Discriminatory ability of GRACE risk score to predict outcomes in patients with Takotsubo syndrome
  • Miss Ervina Shirka
    Digital health analysis - Usefulness of clinical decision support system as tool of good clinical practice in patients at low risk of coronary artery disease. The ARTICA co-operative database.
  • Ms. Laura Kummer
    Advanced heart failure: new aspects - A key role for heme oxygenase-1 in anti-HLA antibody triggered monocyte adhesion and transmigration
  • Mr. Jaroslaw Pawlowski
    Multimodality imaging: from virtual to invasive imaging - Searching for ultimate cardiac data display - Mixed reality interactive visualization of three-dimensional echocardiographic datasets.
  • Dr. Vinayak Nagaraja
    Outcome prediction tools after valve intervention - Impact of elixhauser comorbidity score on the outcomes of transcatheter aortic valve replacement
  • Dr. Ekaterina Dudinskaya
    Hypertension treatment - New features of use of moxonidine as telomerase activator

Winners by sessions

Tuesday 28 August
  • Asst. Prof. Ashley Burch
    Renal failure and cardiovascular disease - Benefit of wearable cardioverter defibrillator in patients with end stage renal disease
  • Dr. Vinayak Nagaraja
    Outcome prediction tools after valve intervention - Impact of elixhauser comorbidity score on the outcomes of transcatheter aortic valve replacement
  • Dr. Ify Mordi
    Diagnostic toolkit for a dilated aorta - The novel biomarker plasma desmosine, a marker of elastin breakdown, is an independent predictor of abdominal aortic aneurysm events independent of aneurysm size
  • Dr. Anna Nordenskjold
    Prognosis of ACS: how to predict and improve - Reinfarction in patients with previous myocardial infarction with non-obstructive coronary arteries (MINOCA), findings at coronary angiography
  • Dr. Fabian Ammon
    Cardiac CT in patients with valvular heart disease - CT-derived left ventricular global strain in aortic stenosis patients referred for transcatheter aortic valve implantation: a head-to-head comparison with echocardiography 
  • Dr. Simonetta Scalvini
    Rehabilitation in heart failure - Cardiac rehabilitation referral in lombardy region: a population study on incident cases from 2005 to 2012
  • Miss Sophie Lepropre
    Platelets - AMPK-ACC signaling modulates platelet phospholipids content and potentiate platelet function and thrombus formation.
  • Dr. Morten Lamberts
    Oral anticoagulants : news from large trials and registries - Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study
  • Dr. David C Peritz
    Atrial fibrillation ablation - The role of left atrial fibrosis progression detected by LGE-MRI on the post-ablation atrial fibrillation recurrence
  • Prof. Michael Kuhne
    Atrial fibrillation ablation - Prevalence and management of atrial thrombus in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation
  • Dr. Bahira Shahim
    Controversies in cardiovascular risk assessment and prevention - Optimizing outreach strategy to identify individuals at risk for diabetes and/or cardiovascular disease: a study of the Sodertalje municipality in Sweden
  • Dr. Florian Schlotter
    Novel determinants of aortic valve calcification - Sortilin is a key driver of fibrocalcific aortic valve disease
  • Mr. Dominik Nelles
    Structural cardiac interventions - In-vitro comparison of stability, sealing and deformation of two LAA occlusion systems
  • Dr. Jeremie Abtan
    Acute coronary syndromes: treatment and revascularisation - Prevalence, clinical characteristics and outcomes of procedural complications of percutaneous coronary intervention in non ST-elevation myocardial infarction: insights from the TAO trial
  • Dr. Eduardo Casas Rojo
    Echocardiography - Technology - Hybrid imaging fusion of 3D speckle-tracking stress echocardiography and multislice CT coronary angiography (validation study).
  • Mr. Rahat Muslem
    Predictors of outcome after LVAD implantation - Pre-operative liver dysfunction is associated with higher mortality rates at 1-year after left ventricular assist device implantation.
  • Dr. Christine Quast
    Heart valves: from development to disease - Lack of endothelial nitric oxide synthase leads to aortic valve stenosis in aging mice
  • Dr. Wen-Yi Yang
    Hypertension Pathophysiology and Risk - Prognostic value of nocturnal dipping status is driven by nighttime blood pressure level
  • Dr. Serge Harb
    Atrial fibrillation - Anticoagulation - Effect of anticoagulation on mortality by CHADSVASC score in patients with atrial fibrillation: comparison to patients without atrial fibrillation 
Monday 27 August
  • Miss Rubina Attar
    Psychiatric and neurologic disorders and heart disease. Just a coincidence? - Development of coronary procedures following a myocardial infarction in patients with schizophrenia
  • Dr. Lauge Ostergaard
    Diagnostic progress in endocarditis - Incidence of infective endocarditis in patients considered at moderate risk
  • Mr. Kaneshka Masdjedi
    Coronary physiology and beyond - The predictive value of Pd/pa and resting diastolic pressure ratio (DPR) on 1-year adverse cardiovascular event following contemporary percutaneous coronary intervention
  • Miss Deborah Malden
    Latest registry data on coronary disease outcomes - Coronary heart disease in relation to general and central adiposity in the UK Biobank: A cohort study of 500 000 men and women
  • Dr. Fabian Islas
    Assessment of valve disease - Procedural TAVI results better predict the evolution of mitral regurgitation rather than mitral valve features itself.
  • Ms. Laura Kummer
    Advanced heart failure: new aspects - A key role for heme oxygenase-1 in anti-HLA antibody triggered monocyte adhesion and transmigration
  • Dr. Alessandra Ciullo
    Stem cells and cardiac repair - Superior exosome-mediated paracrine effects of cardiac progenitor cells compared to bone marrow mesenchymal stem cells derived from the same patient for cardiac repair
  • M.r Niccolo' Maurizi
  • Remote patient monitoring and telemedecine - Telemedicine cardiovascular screening program in low-income settings by smartphone based technology
  • Dr. Amitava Banerjee
    Atrial fibrillation - Stroke prevention - Making sense of real world evidence: addressing the uncertainties surrounding anticoagulation for stroke prevention in non-valvular atrial fibrillation
  • Dr. Sameer Mehta
    Health economics and policy to improve cardiovascular care and outcomes - Economic impact of avoiding unnecessary transfer & hospitalization- Results from Latin AmericaTtelemedicine Infarct Network (LATIN)
  • Mr. Niccolo' Maurizi
    Cardiomyopathies: diagnosis and outcome - Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy
  • Dr. Stephane Fournier
    Complex decisions in coronary intervention - Long-term natural history of coronary artery bypass grafts depending on the initial haemodynamic significance of the native stenotic coronary arteries
  • Dr. Francesco Costa
    ACS diagnosis and treatment - Exploring the value of the PRECISE-DAPT score after complex percutaneous coronary intervention to inform dual antiplatelet therapy duration decision-making.
  • Assoc. Prof. Erik Lerkevang
    Grove Insights from coronary CT imaging - Aspirin for prevention of cardiovascular events: an analysis of 27,451 patients from the Western Denmark Cardiac Computed Tomography Registry
  • Dr. Maria Angela Losi
    Skeletal muscle and energy metabolism: do they matter in heart failure? - Depressed myocardial energetic efficiency is associated with increased risk of incident heart failure: the strong heart study
  • Dr. Albert Busch
    Role of non coding RNAs in cardiovascular diseases - Long non-coding RNA H19 induces abdominal aortic aneurysms
  • Dr. Ekaterina Dudinskaya
    Hypertension treatment - New features of use of moxonidine as telomerase activator
  • Dr. Valerio Zaca'
    Novel trends in device therapy - Management of complications following ICD replacement/upgrade: preliminary results of the health care resource utilization analysis from the DECODE registry
Sunday 26 August
  • Dr. Jairo Borges
    The ageing heart: a target for interventions and aggressive pharmacotherapy - Normal blood pressure by ACC / AHA 2017 is associated with higher mortality in older adults with hypertension over 1 year. Results of the SARCOS study.
  • Dr. Guillem Casas
    Left ventricular noncompaction - Risk of systemic embolisms in left ventricular noncompaction
  • Dr. Teresa Trenkwalder
    Transcatheter aortic valve intervention - Prophylactic ECMO for periprocedural support in patients with reduced left ventricular ejection fraction undergoing TAVI
  • Mr. Jeff Smit
    Diabetes-associated coronary artery disease - Diagnostic performance of quantitative flow ratio in diabetic and non-diabetic patients
  • Mr. Jaroslaw Pawlowski
    Multimodality imaging: from virtual to invasive imaging - Searching for ultimate cardiac data display - Mixed reality interactive visualization of three-dimensional echocardiographic datasets.
  • Dr. Daniel Pan
    Imaging in acute heart failure - Relationship of the chest x-ray and outcome in patients with hospitalised heart failure
  • Dr. Ralf Erkens
    Reperfusion injury and infarct remodelling - Endothelial dysfunction and loss of cardioprotection by remote ischemic preconditioning in type 2 diabetic mice: restoration by inhibition of proline-rich tyrosine kinase 2 and eNOS reactivation
  • Assoc. Prof. Charalambos Vlachopoulos
    Optimal surrogate endpoints of drug response - Acute and chronic effect of ticagrelor versus clopidogrel on aortic stiffness
  • Dr. Ryo Nishinarita
    Atrial fibrillation - General 2 - SGLT 2 inhibitor suppresses atrial fibrillation in the canine model of atrial fibrillation.
  • Mr. Stephan Michel
    Refining secondary prevention - Intensive prevention program after myocardial infarction: how can LDL cholesterol be reduced and how long are intensive prevention efforts needed?
  • Mr. Jean-Luc Hooglugt
    Congenital Heart Disease - New insights - Efficacy and compliance of long-term, individualised exercise training in adults with congenital heart disease and heart failure symptoms: a randomized controlled trial
  • Dr. Leonardo Seoane
    Modifying outcomes in cardiovascular surgery - Prognostic value of the leukoglycaemic index in postoperative of coronary artery bypass grafting
  • Dr. Fernando Scudiero
    Specials in cardiology: obstructive sleep apnea and Takotsubo syndrome - Discriminatory ability of GRACE risk score to predict outcomes in patients with Takotsubo syndrome
  • Dr. Regina Sorrentino
    Echocardiography in non-ischemic cardiomyopathies - Prominent reduction of subepicardial strain and increase of transmural myocardial gradient in native Anderson-Fabry disease: a speckle tracking echocardiography study
  • Prof. Subodh Verma
    Targeting reverse remodelling in heart failure - Empagliflozin prevention of heart failure development in diabetes is associated with an improvement in cardiac energy producition
  • Dr. Mario Zierden
    Inflammation and vascular disease - PI3-kinase delta protects against atherosclerosis progression by controlling regulatory T-cell homeostasis and function
  • Dr. Panagiotis Xaplanteris
    Clinical aspects of hypertension - A clinical score to predict elevated arterial stiffness: derivation and validation in 3,943 hypertensive patients
  • Mr. Tobias Graversgaard Hansen
    Atrial fibrillation - General 1 - Atrial fibrillation and infection among acute patients in the Emergency Department: a multicentre cohort study of prevalence and prognosis
Saturday 25 August
  • Dr. Simone Biscaglia
    Surprising news on exercise, fitness and cardiovascular disease: Prognostic impact and major determinants of physical activity level in a real-life SCAD population: insights from the CLARIFY registry
  • Mr. Pierre Guignant
    Understanding pulmonary hypertension: breakthrough findings in translational science: Phenomapping for re-classification of patients with pulmonary hypertension at high risk. 
  • Dr. Romain Chopard
    Venous thrombosis and anticoagulation: Prognostic impact of non-compliance with guidelines-recommended treatment of acute pulmonary embolism: Results of a prospective multicenter registry
  • Dr. Christopher DeZorzi
    Cardiac arrest & outcome: can we do better?: Validity of administrative billing codes for identifying patients with cardiac arrest
  • Dr. Victor Marcos Garces
    CMR for outcome prediction: Vasodilator stress cardiovascular magnetic resonance imaging predicts long-term cardiac death and all-cause death in patients with known or suspected coronary artery disease
  • Mrs. Salimah Hassan
    New aspects of heart failure treatment: Heart failure specialist nurse-led day case ambulatory management with intravenous diuretics reduces hospitalisations for acute decompensated heart failure irrespective of ejection fraction
  • Miss. Ervina Shirka
    Digital health analysis: Usefulness of clinical decision support system as tool of good clinical practice in patients at low risk of coronary artery disease. The ARTICA co-operative database.
  • Prof. Robert Rosenson
    Atrial fibrillation, stroke and cardiovascular risk: Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations
  • Dr. Andres Miranda
    Ventricular arrhythmias and sudden cardiac death - treatment: Stellate ganglion block in patients with ventricular arrhythmias, an innovative procedure that must be part of electrophysiologist therapeutic arsenal

Moderated Posters Awards 2017

Congratulations to the winners of the Moderated Posters Awards Sessions 2017!

Overall winners by topics

  • Dr. Elena Arbelo
    Ventricular arrhythmias: Improved treatment and risk prediction: Long-term prognosis of Brugada syndrome patients with syncope
  • Dr. Takuma Aoyama
    Comorbidities in heart failure: Lectin-like oxidized LDL receptor-1 (LOX-1) in cardiomyocytes (CMs) is involved in the pathogenesis of doxorubicin (DOX)-induced cardiomyopathy 
  • Prof. Joerg Hausleiter
    Completing the valvular heart disease puzzle: Six-month results of transcatheter edge-to-edge repair of severe tricuspid regurgitation
  • Dr. Jonas Faxen
    Impact of modifiable risk factors on patient outcomes on cardiac ICU: Serum potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspicion of acute coronary syndrome
  • Mr. Michal Jaworek
    Novelties in left atrial interventions: Right ventricular papillary muscles approximation for functional tricuspid regurgitation treatment - in-vitro feasibility study
  • Mr. Grimur Hognason Mohr
    Diabetes mellitus: from "omics to complications": Use of insulin providers versus insulin sensitizers and risk of out-of-hospital cardiac arrest - a nationwide case-time-control study
  • Dr. Marco Witkowski
    Inflammation, diabetes and their influence on the heart: Metformin epigenetically regulates tissue factor expression in diabetes
  • Miss Laura Korte
    Vascular remodelling: Vasorin regulates smooth muscle cell differentiation and neointima formation 
  • Dr. Vlad Ciobotaru
    Computer modelling: Value of 3D printed left atrial appendix for predicting peri-prosthetics leaks and its usefulness in large cohort for guiding device optimal position in percutaneous left atrial appendage occlusion.

Winners by sessions

Tuesday 29 August PM
  • Dr. Sergey Mikheev
    Cardiovascular surgery: Hypoxic-hyperoxic preconditioning: a novel technique for myocardial protection against ischemia-reperfusion injury in coronary surgery
  • Dr. Simon David Christopher Deseive
    Coronary CTA: plaque imaging: Association of low-attenuation Plaque Volume with cardiovascular risk factors
  • Dr. Takuma Aoyama
    Comorbidities in heart failure: Lectin-like oxidized LDL receptor-1 (LOX-1) in cardiomyocytes (CMs) is involved in the pathogenesis of doxorubicin (DOX)-induced cardiomyopathy
  • Dr. Francisco Marin
    Outcomes in atrial fibrillation: room for improvement? Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.
  • Mr. Emile Nyns
    Cellular and molecular electrophysiology: Local epicardial light pulse terminates ventricular arrhythmias in the adult rat heart upon optogenetic modification: towards biological shockless defibrillation.
  • Associate Prof. Mamoun Alhamadsheh
    Cardiac amyloidosis: AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy
  • Mr. Mark Roland de Jong
    Interventions in hypertension management: Renal nerve stimulation identifies aorticorenal innervation and prevents inadvertent ablation of parasympathetic nerves during renal sympathetic denervation
  • Miss Marina Martinez Matilla
    Genetic basis: Study of pharmacodynamic and pharmacokinetic-mediated genetic susceptibility to drug-induced arrhythmia and sudden cardiac death
  • Dr. Dilek Akkan
    Diagnostic modalities in stable CAD: Prediction of standard of care guided coronary revascularisation by FFRct is preserved across a broad range of coronary calcification.
Tuesday 29 August AM
  • Mr. Michal Jaworek
    Novelties in left atrial interventions: Right ventricular papillary muscles approximation for functional tricuspid regurgitation treatment - in-vitro feasibility study
  • Associate Prof. Enrico Gianluca Caiani
    Big data: Automated classification of health apps into medical specialties by using text analytics
  • Dr. Peter Godsk Jorgensen
    Fresh look at heart failure: Presence of micro- and macroalbuminuria and association with cardiac mechanics in type 2 diabetes
  • Dr. Ines Silveira
    Time to go to rehab - Best of cardiac rehabilitation: Impact of cardiac rehabilitation in obese patients with coronary artery disease
  • Miss Laura Korte
    Vascular remodelling: Vasorin regulates smooth muscle cell differentiation and neointima formation 
  • Dr. Jacob Schultz
    What is new in venous thromboembolism? A novel experimental in vivo model of acute pulmonary embolism 
  • Prof. Kazem Rahimi
    Systemic and organ adaptation in hypertension: Elevated blood pressure and risk of mitral regurgitation
  • Associate Prof. Yoshikazu Goto
    Sudden Cardiac Death and ICD: Impact of emergency medical services response time on benefits of bystander-initiated cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest
  • Dr. Ayodeji Awoyemi
    CAD: role of inflammation and immunity: Markers of gut leakage are associated with cardiovascular events in a high-risk population
Monday 28 August PM
  • Dr. Sergio Moral
    Advances in cardiovascular surgery: Are morphologic findings of aortic intramural haematoma predictors of mortality in acute phase?
  • Dr. Vlad Ciobotaru
    Computer modelling: Value of 3D printed left atrial appendix for predicting peri-prosthetics leaks and its usefulness in large cohort for guiding device optimal position in percutaneous left atrial appendage occlusion.
  • Associate Prof. Siv Fokstuen
    Heart failure - Diagnostic assessment: Targeted exome sequencing for mendelian cardiac disorders within the Genome Clinic in Geneva.
  • Dr. Attila Olah
    Sports cardiology: adaption or disease: Characterization of myocardial sarcomerdynamics and myocardial sarcomeric protein alterations in a rodent model of athlete's heart
  • Dr. Christian Werner
    Cardiac degeneration and senescence: Prospective study of differential effects of aerobic endurance, interval and resistance training on telomerase activity and telomere length in circulating mononuclear cells
  • Dr. Natalya Novikova
    CTEPH: Catheter-directed and surgical therapy: Pulmonary artery denervation for improving outcome in patients with residual pulmonary hypertension after pulmonary thromboendarterectomy.  Evaluation of results 12 months after PADN.
  • Dr. Yu Taniguchi
    CTEPH: Catheter-directed and surgical therapy: Poor subpleural perfusion as a predictor of failure after balloon pulmonary angioplasty for non-operable chronic thromboembolic pulmonary hypertension
  • Mr. Georg Wolff
    Remaining in the spotlight: antiplatelet agents: Efficacy and safety of perioperative aspirin therapy in non-cardiac surgery: a systematic review and comprehensive meta-analysis of randomized controlled trials
  • Prof. Dimitry Duplyakov
    Progress in stroke prevention in atrial fibrillation: Adherence to anticoagulant drugs in patients with atrial fibrillation and stroke in real clinical practice 
  • Associate Prof. Alexandru Schiopu
    Alternative treatments for myocardial ischaemia? Short-term blockade of the S100A8/A9 alarmin in the immediate post-myocardial infarction period inhibits acute myocardial inflammation and preserves myocardial repair.

Monday 28 August AM
  • Dr. Lisa Voigtlaender
    Transcatheter aortic valve implantation: Prognostic impact of cachexia after transcatheter aortic valve implantation in patients with severe aortic valve stenosis
  • Dr. Anne Cornelissen
    Next generation nuclear cardiology imaging: Glutamate carboxypeptidase II expression-dependent microPET visualization of reendothelialization after balloon denudation in a rat model: a novel tool for non-invasive in vivo molecular imaging
  • Dr. Gianluca Borio
    Ventricular function and haemodynamics: Pulmonary arterial compliance is a major determinant of right ventricular dysfunction: an echocardiographic/invasive hemodynamic study
  • Associate Prof. Kathryn Wood
    Novelties in acute and chronic nursing care: Do symptoms correlate with underlying rhythm in patients after atrial fibrillation ablation?
  • Assistant Prof. Nicola Ferri
    Lipid metabolism: Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: role of the small G protein Rac1
  • Miss Annakaisa Tirronen
    Lipid metabolism: VEGF-B knockout rescues hyperlipidaemia and altered chylomicron metabolism induced by VEGF-D knockout in atherogenic mouse model
  • Prof. Joerg Hausleiter
    Completing the valvular heart disease puzzle: Six-month results of transcatheter edge-to-edge repair of severe tricuspid regurgitation
  • Dr. Athanasios Angelis
    Hypertension and bed-time stories: Differences in macrovascular and microvascular changes between  treated and never treated hypertensive males with erectile dysfunction
  • Miss Kirsty Webb
    The basic science of arrhythmias - Mechanisms and Pathophysiology: Obesity increases the propensity for atrial arrhythmias
  • Dr. Jonas Faxen
    Impact of modifiable risk factors on patient outcomes on cardiac ICU: Serum potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspicion of acute coronary syndrome
Sunday 27 August PM
  • Miss  Laura Kerkmeijer
    Long-term outcomes in challenging subjects: Incidence, determinant and temporal impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis
  • Dr. Guilherme Pessoa Amorim
    Diastolic function and left atrial function: Left atrial function predicts new-onset atrial fibrillation after aortic valve replacement independently from atrial enlargement
  • Dr. Maria Sanz
    Mechanical circulatory support and heart transplantation: Cardiopulmonary, vascular and biomarker responses to acute hypoxic stress  following cardiac transplantation
  • Mr. Grimur Hognason Mohr
    Diabetes mellitus: from "omics to complications": Use of insulin providers versus insulin sensitizers and risk of out-of-hospital cardiac arrest - a nationwide case-time-control study
  • Mrs. Yuka Hayashi
    Regulation and cardiac metabolism: The pathological role of coagulation factors in promoting brown adipose tissue dysfunction and systemic metabolic disorder in obesity.
  • Ms. Alexandra van Dissel
    Novel  insights in congenital heart disease: A multi-biomarker model identifies patients with PAH-CHD at highest risk for mortality
  • Dr. Azra Mahmud
    Hypertension pathophysiology: Age and gender related differences in invasive central pulsatile heamodynamics versus. non-invasive brachial pressures in a large arab population
  • Dr. Efstathios Papatheodorou
    Non-invasive diagnostic methods in cardiac arrhythmias: Validation of the proposed Shanghai Brugada Syndrome Score (SBrS) in a cohort of relatives of Sudden Arrhythmic Death Syndrome (SADS) victims.
  • Dr. Ramon A. Calvino Santos
    What's hot in STEMI? Complete revascularisation versus stress echocardiography-guided revascularisation in patients with ST-segment elevation myocardial infarction and multivessel disease (CROSS-AMI): a clinical trial.
Sunday 27 August AM
  • Dr. Michel Zeitouni
    Complications after cardiac interventions: Should we care about post-procedural troponin in elective coronary stenting?
  • Dr. Patrick Behm
    CMR in acute coronary syndromes and myocarditis: MR-guided endomyocardial biopsy in a preclinical in vivo model
  • Dr. Brian Bridal Loegstrup
    Unmet  challenges in heart failure: Incidence of heart failure and ischemic heart disease in patients with rheumatoid arthritis: A Danish population based study, 1995-2016.
  • Dr. Luis Eduardo Juarez-Orozco
    Cardiovascular risk prediction models: for improvement? Improving the value of clinical variables in the assessment of cardiovascular risk using Artificial Neural Networks
  • Mr. Maximilian Mauler
    Ischaemia and protection: Platelet serotonin aggravates myocardial reperfusion injury via degranulation
  • Dr. Anna Reid
    Cardiomyopathy in Fabry disease: Comprehensive cardiovascular magnetic resonance assessment of anderson-fabry cardiomyopathy- natural history and assessment of treatment effect
  • Dr. Marco Witkowski
    Inflammation, diabetes and their influence on the heart: Metformin epigenetically regulates tissue factor expression in diabetes
  • Dr. Elena Arbelo
    Ventricular arrhythmias: Improved treatment and risk prediction: Long-term prognosis of Brugada syndrome patients with syncope
  • Dr. Kensuke Matsushita
    ACS: from acute management to long-term outcomes: Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome.
Saturday 26 August
  • Dr. Victor Boileve
    3D echocardiography in daily clinics: What causes mitral annulus dilatation-A three-dimensional transesophageal study
  • Dr. Rudin Pistulli
    Fat and skeletal muscles in heart failure: Serum metabolomic profiling of patients with heart failure with reduced ejection fraction reveals differences between ischemic and dilated cardiomyopathy
  • Prof. Robert Rosenson, FESC
    Lipid-lowering therapy: old faces and new issues: Statin use among HIV-infected adults by cardiovascular disease risk status
  • Dr. Sezin Aday
    Vascular degeneration and restoration: Artificial exosomes for post-ischemic vascular regeneration
  • Dr. Charlotte Andreasen
    A look at aortic stenosis from different angles: Timing after stroke and risk of recurrent stroke and mortality in aortic valve replacement surgery
  • Dr. Thomas Hinton
    The brain in hypertension: Are cerebrovascular variants causal in the development of hypertension?
  • Ms. Melissa Middeldorp
    Atrial fibrillation ablation - Outcomes and predictors: The influence of gender on 1-year outcomes of patients undergoing primary AF ablation
  • Dr. Aviv Avraham Shaul
    Latest on acute coronary syndromes: Early versus Delayed Angiography in Non-ST-Elevation Myocardial Infarction - Insights from ACSIS
  • Dr. Maria Isabel Koerber
    Transcatheter mitral interventions: Bleeding complications following percutaneous mitral valve repair with the MitraClip

Moderated Posters Awards 2016

Congratulations to the winners of the Moderated Posters Awards Sessions 2016!

Overall winners by topics

  • Dr. Christian Werner
    Basic Science: Telomerase deficiency is associated with impaired diastolic function, mitochondrial dysfunction and increased fibrosis in a murine model of cardiac pressure overload
  • Prof. Christopher Paul Cannon
    Prevention, Rehabilitation, Sports Cardiology, Nursing, Ageing: Modeling lipid-lowering therapy intensification in the real world: how many patients with atherosclerotic cardiovascular disease would need a PCSK9 inhibitor?
  • Dr. Jasper Boeddinghaus
    Ischaemia, Coronary Artery Disease, Acute Cardiac Care, Acute Coronary Syndromes: Direct comparison of four very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I
  • Dr. Oscar Miro
    Heart Failure, LV Dysfunction: Predictors of 30-day mortality in patients with acute heart failure at emergency department admission: derivation and validation of the MEESSI-AHF scale
  • Prof. Oussama Wazni
    Arrhythmias, Pacing, Resynchronisation: Cardiac implantable electronic device infection: variability in clinical presentation and outcomes in patients with or without previously abandoned leads
  • Dr. Alexander Egbe
    Congenital, Valvular Myopericardial Diseases, Pulmonary Circulation: Outcomes in moderate mixed aortic valve disease: is it time for a paradigm shift?
  • Dr. Pedro Canas da Silva
    Interventions, Peripheral Circulation, Stroke, Surgery: Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry
  • Dr. Thomas Steen Gyldenstierne Sehested
    Hypertension, Pharma: Dose-response relationship between proton pump inhibitor use and associated risk of myocardial infarction: a nationwide cohort study
  • Mr. Niklas Dyrby Johansen
    Cardiac Imaging & e-Technology: Diastolic dysfunction revisited: a new, feasible and unambigious classification predicts major cardiovascular events

Winners by sessions

Tuesday 30 August - 15:00
  • Dr. Alexander Egbe
    New insights in aortic valve stenosis: Outcomes in moderate mixed aortic valve disease: is it time for a paradigm shift?
  • Prof. Ping-Yen Liu
    Cancer and cardiotoxicity: from bench to bedside: CCAAT/enhancer binding protein delta contributes to an earlier phase of pro-inflammatory response in doxorubicin related cardiomyopathy
  • Dr. Anna-Karin Nume
    Management of syncope: Return to work is high following syncope: a nationwide study
  • Dr. Thomas Steen Gyldenstierne Sehested
    Lipid-lowering agents - New perspectives: Dose-response relationship between proton pump inhibitor use and associated risk of myocardial infarction: a nationwide cohort study
  • Ms. Nefissa Hammache
    Common clinical applications of CMR: Relationship between the morphology of myocardial infarction scar border assessed by cardiac magnetic resonance and the inducibility of ventricular tachycardia
  • Assoc. Prof. Elfriede Ruttmann-Ulmer
    Valve repair and assist devices: Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis
  • Assist. Prof. Kohei Yamamizu
    Cell regenerative therapy: Human iPS cell-engineered 3D-cardiovascular tissue by stacking sheets with gelatin hydrogel microspheres for cardiac regenerative medicine
  • Dr. Andreia Pereira
    Cardiovascular risk scores: novel tunes in a familiar music: Reclassification of the Intermediate group classified according to HEARTSCORE taking in consideration individual genetic predisposition to Coronary artery disease.
  • Dr. Reza Masoomi
    Challenging preconceptions in acute coronary syndromes.: In-hospital management and outcomes in pregnancy associated acute myocardial infarction: results from the United States national inpatient sample database
Tuesday 30 August - 10:00
  • Assoc. Prof. Francesco Paneni
    The immune system in cardiovascular disease: Methyltransferase Set7 drives vascular inflammation and endothelial dysfunction in obesity
  • Dr. Hironori Uzuka
    Physiology of stenting from bench to bedside: Renal denervation suppresses coronary hyperconstricting responses after DES implantation in pigs in vivo  -Evidence for the kidney-brain-heart interactions
  • Dr. Lida Khurrami
    Novel clinical implications of cardiac CT: Association between aortic valve calcification quantified using non-contrast cardiac CT and aortic valve stenosis assessed by transthoracic echocardiography in the general 
  • Assoc. Prof. Sarah Chua
    Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension: Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan
  • Mr. Yann Xu
    Antithrombotic therapy in atrial fibrillation 2: Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants compared to warfarin in routine practice: interim results from a multi-centre all-comer cohort
  • Dr. Matthew Barrett
    Cardiomyopathies: Eosinophilic myocarditis in patients on dobutamine therapy: an underappreciated but not uncommon phenomenon
  • Prof. Christopher Paul Canon
    Are we ever going to get to lipid goals?: Modeling lipid-lowering therapy intensification in the real world: how many patients with atherosclerotic cardiovascular disease would need a PCSK9 inhibitor?
  • Dr. Isabel Zegri Reiriz
    Current trends in endocarditis: Usefulness of 18F-Fluordeoxyglucose positron emission tomography/computed tomography for diagnosis of prosthetic valve and intracardiac device infective endocarditis 
  • Dr. Christian Stratz
    Mechanisms of platelet activation: Evaluation of immature platelet parameters as compared to  established predictors of platelet reactivity after thienopyridine loading
Monday 29 August - 15:30
  • Dr. Cho-Kai Wu
    Diastolic function: Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices
  • Mr. Kasper Gadsboell
    Antithrombotic therapy in atrial fibrillation 1: Increased use of oral anticoagulants in patients with atrial fibrillation: Nationwide temporal trends in Denmark from 2005 to 2015
  • Dr. Chang Wei-Ting
    Complications of hypertension: Evaluation of coronary flow velocity by Doppler echocardiography in the treatment of hypertension with the ACEi/ARB: correlation to the histological cardiac fibrosis
  • Dr. Rudolf Werner
    New developments in cardiovascular SPECT and PET: Detection of focal inflammatory CD68-positive macrophage infiltrates by 18F-FDG uptake in a rat model of autoimmune Myocarditis (EAM-model)
  • Dr. Charles Ilsley
    New aspects on PCI: Prognostic significance of incomplete revascularization and bystander coronary anatomy following percutaneous coronary intervention: an observational study of 6,755 patients with multivessel disease
  • Dr. Muhammad Aslam
    Vascular biology: Impact of the adiponectin paralog CTRP13 on endothelial cells
  • Dr. Andreia Pereira
    Improved risk prediction and subsequent action: Net Reclassification index of a genetic risk score and standard Framingham risk stratification in a european population
      • Prof. Anetta Undas
        Advances in pulmonary embolism: Prothrombotic fibrin clot phenotype is associated with recurrent pulmonary embolism following discontinuation of anticoagulant therapy
      • Dr. Jens-Uwe Roehnisch
        Coronary revascularisation: how and how much: Transradial vs. transfemoral access in patients with ACS: bleeding complications and outcome
Monday 29 August - 10:00
      • Dr. Jacob Klein
        Prognosis and cost-effectiveness of cardiac rehabilitation: Mortality benefit of cardiac rehabilitation after myocardial infarction in the modern era
      • Dr. Yanwen Wang
        Ion channels: from the molecular level to integrative biology: Circadian rhythm in heart rate is due to an intrinsic circadian clock in the sinus node
      • Dr. Muthiah Vaduganathan
        PCI complications: Bleeding events and subsequent 30-day and 1-year mortality after percutaneous coronary intervention: a contemporary pooled patient-level analysis from the CHAMPION 
      • Ms. Giorgia Maria Bosi
        Computer modelling and simulation: A validated computational framework to simulate transcatheter aortic valve implantation in patients before the procedure
      • Mr. Arjun Pandey
        Lifestyle and blood pressure: The impact of obesity and diet-induced weight loss on non-dippers and circadian BP patterns
      • Dr. Tze-Fan Chao
        Comorbidities and atrial fibrillation: Presence of diabetic complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation
      • Mr. Julian Mustroph
        Novel pharmacological therapy in chronic heart failure: The CaMKII inhibitor RA123456 attenuates heart failure and prevents ventricular and atrial arrhythmias in vivo
      • Dr. Keimei Yoshida
        Basic mechanisms in pulmonary hypertension: Inhibition of nuclear factor-kappaB-mediated inflammation improves RV function in rats with pulmonary artery banding
  • Ms. Caroline Sindet-Pedersen
    Insights on thrombosis and anticoagulants: Familial clustering of venous thromboembolism - A Danish nationwide cohort study
  • Ms. Charlotte Holst Hansen
    Insights on thrombosis and anticoagulants: Markers of thrombin generation in patients with ST-elevation myocardial infarction are associated with long term clinical outcome 
Sunday 28 August - 15:30
  • Dr. Christian Werner
    Cardiac biology and senescence : Telomerase deficiency is associated with impaired diastolic function, mitochondrial dysfunction and increased fibrosis in a murine model of cardiac pressure overload
  • Dr. Ziad Hijazi
    The relevance of biomarkers: a never ending story: Growth differentiation factor 15 is an independent marker of risk of major bleeding in atrial fibrillation: insights from the RE-LY trial
  • Dr. Christian Puelacher
    Comorbidities in coronary artery disease: what matters?: Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of exercise-induced myocardial ischemia
  • Dr. Daniel Rodriguez Munoz
    Improving clinical response to CRT: Optimal coupling between vortical flow in left ventricular outflow tract and left ventricular ejection: a result of atrio-ventricular delay optimization
  • Prof. Massimo Imazio
    Hot issues in pericardial and myocardial disease: Treatment of idiopathic recurrent pericarditis with anakinra. A multicenter randomized controlled clinical trial.
  • Dr. Pedro Canas da Silva
    Current data on TAVI outcomes: Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry
  • Dr. Kyriakos Dimitriadis
    Metabolic factors and biomarkers: Uric acid levels predict coronary artery disease in essential hypertension: Data from a Greek 8-year-follow-up study 
  • Dr. Anusith Tunhasiriwet
    Novel ultrasonic techniques : Novel index of right ventricular myocardial stiffness in patients with pulmonary hypertension: correlations with cardiac morphology and who functional class
Sunday 28 August - 10:00
  • Dr. Giuseppe Derosa
    Improving diagnosis in cardiomyopathies: Cardiac magnetic resonance in arrhythmogenic  right ventricular cardiomyopathy:  combined functional assessment and tissue characterization versus task force criteria. 
  • Mr. Michal Tkaczyszyn
    New targets for biomarkers in heart failure: Adequacy of endogenous erythropoietin levels in anaemic heart failure patients - relationship with disease severity and co-morbidities
  • Assoc.Prof. Finn Lund Henriksen
    Overcoming ventricular arrhythmias and sudden death: Emergency dispatch, global positioning of first responders with distinct roles and automatic external defibrillators - a logistic solution to secure basic life support and defibrillation
  • Prof. Giuseppe Derosa
    Drug treatment of hypertension: Results of the ESCAPE trial: an italian, multi-centre, phase IV, randomized, controlled, open-label trial on the effects of canrenone in hypertensive patients
  • Ms. Yu Jing Mo
    The aortic valve: Resolving inconsistencies between gradient and flow measurements by echocardiography in patients with significant aortic valve stenosis and preserved LV ejection fraction
  • Dr. Guido Parodi
    Factors influencing long term PCI outcomes: Adverse clinical event occurrence beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS study
  • Dr. Sebastiano Sciarretta
    Lipids and platelets: C2238 atrial natriuretic peptide molecular variant determines an increased platelet aggregation through the activation of NOX2 and the reduction of cAMP
  • Dr. Ana Rita Marinheiro
    Up in smoke: the impact of tobacco use and smoking cessation: Effects of smoking and smoking cessation on twenty-four hour blood pressure
  • Dr. Jasper Boeddinghaus
    Optimising outcomes in acute coronary syndrome: Direct comparison of four very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I
Saturday 27 August - 12:30
      • Mr. Kai Knoepp
        Angiogenesis: MiR-146a inhibition augments angiogenesis and myocardial regeneration
      • Mr. Jakob Ledwoch
        Optimising primary PCI: Drug eluting stent vs. bare metal stent in acute myocardial infarction complicated by cardiogenic shock - A substudy of the IABP-SHOCK II-trial
      • Mr. Niklas Dyrby Johansen
        New technologies in echo-ventricular function and myocardial diseases: Diastolic dysfunction revisited: a new, feasible and unambigious classification predicts major cardiovascular events
      • Dr. Amy Elizabeth Burchell
        Target organ damage in hypertension: Magnetic resonance imaging as an assessment tool in hypertension
      • Prof. Oussama Wazni
        Management of device complications and lead extraction: are we getting better?: Cardiac implantable electronic device infection: variability in clinical presentation and outcomes in patients with or without previously abandoned leads
      • Dr. Oscar Miro
        Prognostication in heart failure: Predictors of 30-day mortality in patients with acute heart failure at emergency department admission: derivation and validation of the MEESSI-AHF scale
  • Mr. Joey Kuijpers
    Challenges in congenital heart disease: Aortopathy in various types of adult congenital heart disease
  • Dr. Tee Joo Yeo
    Interplay between exercise and cardiac pathology: The effect of exercise on the aortic root diameter in young elite athletes with bicuspid aortic valve disease.
  • Dr. Alessandro Zorzi
    Interplay between exercise and cardiac pathology: Non-ischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes
  • Dr. Giuseppe Ferrante
    Dual antiplatelet therapy: the long and the short of it!: Long term dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised studies

Moderated Posters Awards 2015

Congratulations to the winners of the Moderated Posters Awards Sessions 2015!

Overall Winners by topics

      • Sander Trenson, Belgium
        Clinical impact and modulation of endothelial (dys)function:  Altered molecular signature of cardiac microvascular endothelium after chronic pressure overload and transition to heart failure
      • Shizuya Yamashita, Japan
        Treatment of hypercholesterolemia. A vision to the future: Effect of K-877, a potent and selective PPAR alpha modulator (SPPARM alpha), on cholesterol efflux from macrophages in dyslipidemic patients
      • Jerrold Levy, United States of America
        Anti-thrombotics in clinical practice: Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study
      • Antonio Brucato, Italy
        Prognosis in pericardial disease: Recurrent pericarditis in children and adolescents.A multicentre cohort study
      • Jeroen Venlet, Netherlands
        Ventricular arrhythmias: stratification and treatment: Critical progressive activation delay after premature stimulation is associated with polymorphic ventricular tachycardia in nonischemic cardiomyopathy: results from the Leiden NICM Study
      • Akshay Suvas Desai, United States of America
        Heart failure therapy: Factors associated with dropout during the run-in period prior to randomization in PARADIGM-HF
      • Ronak Delewi, Netherlands
        Post myocardial infarction outcome: Long term myocardial recovery after revascularization for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging
      • Mahir Karakas, Germany
        Advancing the clinical application of biomarkers: Prognostic value of circulating MicroRNAs in patients with coronary artery disease - results from the AtheroGene study
      • Christian Kupatt, Germany
        New advances in cardiovascular genetics and gene therapy: Impact of diabetes mellitus on Thymosin B4 mediated therapeutic neovascularization
      • Mischa Rijnierse, Netherlands
        Developments in nuclear cardiology, prognosis, risk stratification and management strategies: Effect of beta-blocking therapy on cardiac sympathetic nerve function in patients with idiopathic pulmonary arterial hypertension

Winners by sessions

Tuesday 1 September - 15:30
      • Marc Jolicoeur, Canada
        Management in heart failure: new perspectives:  Influence of angina and revascularization in patients with left ventricular systolic dysfunction and coronary artery disease: insights from the STICH trial.
      • Lars Wallentin, Sweden
        What's next in cardiovascular risk prediction? Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy.
      • Nico Hartmann, Germany
        Outcomes after TAVI: Seven-year outcome after TAVI
      • Oana Mirea, Belgium
        New techniques and new applications in echocardiography:  Effect of afterload increase on left ventricle mechanical dispersion and electromechanical window.
      • Jeroen Venlet, Netherlands
        Ventricular arrhythmias: stratification and treatment: Critical progressive activation delay after premature stimulation is associated with polymorphic ventricular tachycardia in nonischemic cardiomyopathy: results from the Leiden NICM Study.
      • Stephane Fournier, Switzerland
        Reperfusion of STEMI: Circadian variation of intracoronary thrombus aspiration efficacy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
      • Josebe Goirigolzarri Artaza, Spain
        New techniques and new applications in echocardiography:  Validation of 2D strain parameters in the diagnosis of acute rejection after heart trasplantation.
      • Junjing Su, Denmark
        Differentiating pulmonary arterial hypertension from other pulmonary hypertension groups: Impact of atrial contraction on diagnosis of pre- versus post-capillary pulmonary hypertension.
      • Jerrold Levy, United States of America
        Anti-thrombotics in clinical practice:  Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study.
      • Shizuya Yamashita, Japan
        Treatment of hypercholesterolemia. A vision to the future: Effect of K-877, a potent and selective PPAR alpha modulator (SPPARM alpha), on cholesterol efflux from macrophages in dyslipidemic patients.
Tuesday 1 September - 10:00
      • Elizabeth Feijen, Netherlands
        Ominous signs in heart failure: Time-related cumulative incidence of congestive heart failure after childhood cancer treatment; a DCOG LATER study.
      • Mahir Karakas, Germany
        Advancing the clinical application of biomarkers: Prognostic value of circulating MicroRNAs in patients with coronary artery disease - results from the AtheroGene study.
      • Yoshihisa Yamada, Japan
        Cardiovascular dysfunction and repair - Roles of inflammation and immune cells: Sphigosine-mono-phosphate (S1P) induces the migration of Muse cells but not non-Muse cells toward the rabbit post-infarct heart and contributes to the improvement of cardiac function and remodeling.
      • Juliana Reis Pires Martins, Portugal
        Acute phase of STEMI:  Revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel disease in a real world population.
      • S Benedict Freedman, Australia
        Antithrombotic prophylaxis in atrial fibrillation: High burden of potentially avoidable stroke from discontinuation of warfarin therapy in non-valvular atrial fibrillation.
      • Alexios Antonopoulos, Greece
        Advances in cardiac computed tomography imaging:  Epicardial adipose tissue expansion and differentiation status predict myocardial redox state and coronary calcification.
      • Benjamin Alos, France
        Outcomes after TAVI: Seven-year outcome after TAVI
      • Tatsunori Takahashi, Japan
        Understanding pathophysiology from imaging and functional assessment: Usefulness of optical coherence tomography in determining the mechanisms of myocardial infarction in patients without angiographically demonstrable coronary artery disease.
      • Hisaki Makimoto, Japan
        Hypertension and comorbidities: a challenge of treatment:  Diverge responses of cardiac autonomic function to beta-blocker therapy depending on chronic kidney disease.

 

Monday 31 August - 15:30
      • Sanne De Jong, Netherlands
        Heart failure: diversity of phenotyping:  MicroRNAs as a quantitative and prognostic biomarker of interstitial cardiac fibrosis in pressure overloaded mice.
      • Adam Kenneth McDiarmid, United Kingdom
        Differentiating physiological adaptation from cardiac pathology in athletes: Athletic cardiac adaptation is secondary to increased myocyte mass.
      • Javier Barallobre-Barreiro, United Kingdom
        Extracellular matrix, remodelling and inflammation: Glycoproteomics analysis of cardiac extracellular matrix reveals the presence of decorin fragments with anti-myostatin and anti-fibrotic activity.
      • Steen Hansen, Denmark
        Pre-hospital phase of STEMI: Increased dissemination of registered AEDs is associated with higher rate of bystander defibrillation in public locations but not in residential areas - a nationwide study.
      • Elmir Omerovic, Sweden
        Atrial fibrillation in real world: Atrial fibrillation in patients admitted to coronary care units in western Sweden. focus on obesity and lipotoxicity
      • Axel Bauer, Germany
        Information technology applications in cardiology: Assessment of deceleration capacity from short-term recordings  predicts mortality after myocardial infarction.
      • Oliver Husser, Germany
        Aortic stenosis - From basics to prognosis: Combining tumor marker carbohydrate antigen 125 and the logistic EuroSCORE improves risk stratification in patients undergoing transcatheter aortic valve implantation.
      • Sergio Leonardi, Italy
        Prediction models in clinical practice: Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: the CHAMPION experience.
      • Yan Zhang, China, People's Republic of
        Hypertension pathophysiology II: Non-invasive central systolic blood pressure not peripheral systolic blood pressure associated with kidney function decline in a chinese community-based population.
Monday 31 August - 10:00
      • Xavier Jouven, France
        Hypertension treatment: Quality of cardiovascular drugs in street markets and pharmacies in 10 sub-saharan
      • Timm Bauer, Germany
        Management of procedural risks: Disaster in the cath lab - cardiogenic shock induced by procedure: results from the EHS PCI registry.
      • Louise Eske Bruun, Denmark
        Advances in endocarditis: Socioeconomic status and risk of staphylococcus aureus bacteremia - a danish nationwide cohort study .
      • Satish Chacko, United States of America
        Cardiovascular magnetic resonance - Ischaemic heart disease: Prognostic significance of global myocardial perfusion reserve measured using coronary sinus flow during stress cardiovascular magnetic resonance imaging.
      • Abdul Shokor Parwani, Germany
        Different aspects in management of atrial fibrillation: Relationship between reduced left atrial function and electro-anatomical remodeling in patients undergoing atrial fibrillation ablation.
      • Tomasz Mazurek, Poland
        Experimental and clinical research in myocardial ischaemia:  Inflammatory activity of pericoronary adipose tissue in prediabetic patients with NSTE-ACS.
      • Christian Kupatt, Germany
        New advances in cardiovascular genetics and gene therapy: Impact of diabetes mellitus on Thymosin B4 mediated therapeutic neovascularization.
      • Adrian Cid Menendez, Spain
        Impact of smoking cessation on cardiovascular prognosis: myths and reality: Prognostic influence of smoking in patients with an acute myocardial infarction: paradox or confusion? a propensity-score matched analysis.
      • Camilla Hage, Sweden
        Diastolic dysfunction: Inflammatory biomarkers predict HF severity and prognosis in patients with heart failure with preserved ejection fraction. african countries: the seven study.

 

Sunday 30 August - 15:30
      • Joerg Eiringhaus, Germany
        Basic mechanisms in heart failure: Ca-homeostasis in human cardiac hypertrophy and end stage heart failure is directly impacted by modulations of protein phosphatase 1 and -2a activity.
      • Guy De Backer, Belgium
        What does epidemiology teach us about cardiovascular risk? Prevalence and management of familial hypercholesterolaemia in the euroaspire iv project.
      • Alessandra Frigiola, United Kingdom
        Challenges in repaired tetralogy of Fallot: Relation between exercise capacity and skeletal muscle metabolism during exercise in patients with repaired tetralogy of Fallot.
      • Colin Stirrat, United Kingdom
        Cardiovascular magnetic resonance - Translational: Ultrasmall superparamagnetic particles of iron oxide-enhanced magnetic resonance imaging in the assessment of cellular inflammation after myocardial infarction.
      • Giuseppe Boriani, Italy
        Antibradycardia pacing: Time course of detection of new atrial fibrillation (AF) and AF burden in patients with cardiac implanted electronic devices.
      • Federica Ilardi, Italy
        Improving antiplatelets regimen and cardioprotection in coronary patients: Rac-1 as a new target to modulate endothelial function and platelet aggregation in diabetes mellitus.
      • Gemma Vilahur Garcia, Spain
        Diet, lipids and the vasculature: Dyslipidemia impairs high-density lipoprotein cardioprotective effects leading to larger infarcts. HDL-characterization by lipid analysis and differential proteomics.
      • Jouke Bokma, Netherlands
        Challenges in repaired tetralogy of Fallot: QRS fragmentation is superior to QRS duration in the prediction of death or ventricular tachycardia in adults with tetralogy of Fallot.
      • Claudio Muneretto, Italy
        Current status and future directions of coronary artery bypass grafting: Long term follow-up following total arterial versus conventional and hybrid myocardial revascularisation: a propensity-match analysis.
      • Moo Young Rhee, Korea, Republic of
        Hypertension and haemodynamics: Aorta-to-upper arm pulse wave transit time ratio can predict the risk of coronary artery disease and stroke better than pulse wave velocity.
Sunday 30 August - 10:00
      • Konstantinos Toutouzas, Greece
        Myocardial function: The impact of left ventricular function and balloon aortic valvuloplasty on paravalvular leakage in patients undergoing TAVI.
      • Robert Patrick Giugliano, United States of America
        Managing lipids - Statins and beyond: Prospectivev evaluation of cancer in 18,144 patients randomized to ezetimibe vs placebo: a prespecified analysis from the IMPROVE IT trial.
      • Sander Trenson, Belgium
        Clinical impact and modulation of endothelial (dys)function: Altered molecular signature of cardiac microvascular endothelium after chronic pressure overload and transition to heart failure.
      • Debbie Kalkman, Netherlands
        Knowing more about STEMI and non-STEMI: Comparison of 10-Year follow-up mortality rates in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.
      • Anna Polewczyk, Poland
        Complications in devices: Analysis of efficacy and safety of transvenous leads extraction and long term mortality after procedures in women and men.
      • Michael Huntgeburth, Germany
        What's new in imaging for valvular heart disease? Novel method for determination of mitral regurgitation severity before and after percutaneous edge-to-edge mitral valve repair by contrast echocardiography.
      • Milind Desai, United States of America
        Advances in cardiomyopathies: Outcomes of hypertrophic cardiomyopathy patients undergoing non-cardiac surgery: A cohort study with matched non hypertrophic cardiomyopathy patients.
      • Yusuke Tomoi, Japan
        Assessing percutaneous treatment options for PAD: Optimal revascularization strategy for in-stent occlusion after femoro-popliteal stenting.
      • Lorenzo DiCarlo, United Kingdom
        Hypertension: devices and interventions: Transforming the information highway for the clinical management of blood pressure using an ambulatory setting, objective assessment, and digital communication.
Saturday 29 August - 12:30
      • Akshay Suvas Desai, United States of America
        Heart failure therapy: Factors associated with dropout during the run-in period prior to randomization in PARADIGM-HF.
      • Nobutaka Ikeda, Japan
        From pre-diabetes to vascular complications: Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events.
      • Bram Trachet, Switzerland
        News in cardiac anatomy: Branch-related ruptures cause intramural hematoma and dissecting abdominal aortic aneurysm in angiotensin II-infused ApoE -/- mice.
      • Ronak Delewi, Netherlands
        Post myocardial infarction outcome: Long term myocardial recovery after revascularization for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging.
      • Damien Voilliot, France
        Updates on ICD therapy: Primary prevention indication for implantable cardioverter-defibrillator  in post infarct patients: the value of myocardial infarction scar characterization by magnetic resonance imaging.
      • Mischa Rijnierse, Netherlands
        Developments in nuclear cardiology, prognosis, risk stratification and management strategies: Effect of beta-blocking therapy on cardiac sympathetic nerve function in patients with idiopathic pulmonary arterial hypertension.
      • Antonio Brucato, Italy
        Prognosis in pericardial disease: Recurrent pericarditis in children and adolescents.A multicentre cohort study.
      • Yae Matsuo, Japan
        Percutaneous non-coronary techniques for stroke prevention: Long term result of the left atrial appendage closure for stroke prevention in single high volume center.
      • Jan Vaclavik, Czech Republic
        Hypertension pathophysiology I: Hypertension control and medication burden in patients with additional risk factors in central and eastern europe.

Moderated Posters Awards 2014

      • Kazuhiro Matsuo
      • Baris Gencer
      • Karolina Szummer
      • Ling Li Teo
      • Taisuke Ishikawa
      • Ralph Stephan Von Bardeleben
      • Tim Van de Hoef
      • Grzegorz Bilo
      • Murray Matangi

Moderated Posters Awards 2013

      • Bromage Dan
      • Porta Sanchez Andreu
      • Segreti Luca
      • Lourenco Patricia
      • Menezes Alves Da Costa Leandro
      • La Gerche Andre
      • Perazzolo Marra Martina
      • Spescha Remo
      • Khalid Usman
      • Paikin Jeremy
      • Leening Maarten
      • Igland Jannicke
      • Alraies Chadi
      • Verloop Willemien
      • Ujiie Yuichi

Moderated Posters Awards 2012

      • Marrian
      • Takashi Yamada
      • Pierpaolo Pellicori
      • Ismo Anttila
      • Antonios Antoniadis
      • Constantinos O'Mahony
      • Sebastian Szardien
      • Sebastiaan Piers
      • Alexander Lauten
      • Juergen Leick
      • Jef Geens
      • David Erlinge
      • Bruna Gigante
      • Peter Kolkhof
      • Gyongyosi

Moderated Posters Awards 2011

      • Mary N Sheppard
      • Massimiliano Palazzini
      • Kim Lamont
      • Gaetano Maria De Ferrari
      • Gaetano Nucifora
      • Yuan-Hung Liu
      • Christian Ukena
      • Liza Thomas
      • Lelane Van Der Poel
      • Toshinari Onishi
      • Guillaume Jondeau
      • Carsten Skurk
      • Erik Tandberg Askevold

Moderated Posters Awards 2010

      • Philipp Stieger
      • Yoshiji Yamada
      • Anselm Kai Gitt
      • Giovanna Liuzzo
      • Daphne Babalis
      • Milos Taborsky
      • Alberto Bouzas Mosquera
      • Felix Woitek
      • Aaron Kee Fui Wong
      • Nikolaos Bonaros
      • Navin Chandra
      • Caroline Veltman
      • Massimo Lacoviello
      • Carolyn Sp Lam

Moderated Posters Awards 2009

      • Yvette Van Gestel
      • Matteo Cameli
      • Javier Lopez-Diaz
      • Bimmer Claessen
      • Jun Ni
      • Mario Previtali
      • Robert Fisher
      • Susanne Brenner
      • Enrique Santas
      • Christian Templin
      • Ioannis Laoutaris
      • Gianranco Parati
      • Piotr Musialek
      • Thomas Pilgrim

Moderated Posters Awards 2008

      • Anders Sahlen
      • Canan Nebigil
      • Danilo Neglia
      • Nick Clappers
      • Rene A Tio
      • Anastasios Athanasiadis
      • Yu Ting Tan
      • Paola Meregalli
      • Daniel Fernadez Berges
      • Alessandra Serio
      • Renato Lopes
      • John Eikelboom
      • David Busseuil
      • Robert Gerber
      • Robert Doughty

Moderated Posters Awards 2007

    • Alexander Staudt
    • Martyn Farrer
    • Mateusz Orzalkiewicz
    • Stephan
    • Masaya Tanno
    • Laurent Louis Andre de Kerchove
    • Birke Schneider
    • Stephan Jacobs
    • Stavros Chrysostomakis
    • Fabien Hyafil
    • Roman Arnold
    • Gielsen
    • Fausto Rigo
    • Nika Skoro-Sajer
    • Dorothea Siegel-Axel